Firefly Neuroscience, Inc. (AIFF) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Firefly Neuroscience, Inc. (AIFF) has a cash flow conversion efficiency ratio of -0.154x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-1.49 Million) by net assets ($9.66 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Firefly Neuroscience, Inc. - Cash Flow Conversion Efficiency Trend (2020–2024)
This chart illustrates how Firefly Neuroscience, Inc.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Read AIFF current and long-term liabilities for a breakdown of total debt and financial obligations.
Firefly Neuroscience, Inc. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Firefly Neuroscience, Inc. ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Reservoir Link Energy Bhd
KLSE:0219
|
-0.004x |
|
Aasen Sparebank
OL:AASB
|
0.017x |
|
Murray International Trust
LSE:MYI
|
0.025x |
|
Rubicon Organics Inc
V:ROMJ
|
0.010x |
|
Przedsiebiorstwo Produkcyjno Handlowe Kompap SA
WAR:KMP
|
0.014x |
|
ECA
KLSE:0267
|
0.036x |
|
Castec Korea Co Ltd
KQ:071850
|
0.182x |
|
Neuroscientific Biopharmaceuticals Ltd
AU:NSB
|
-0.029x |
Annual Cash Flow Conversion Efficiency for Firefly Neuroscience, Inc. (2020–2024)
The table below shows the annual cash flow conversion efficiency of Firefly Neuroscience, Inc. from 2020 to 2024. For the full company profile with market capitalisation and key ratios, see AIFF market cap.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $-375.00K | $-6.16 Million | 16.413x | +182.37% |
| 2023-12-31 | $109.00K | $-2.17 Million | -19.927x | -1554.53% |
| 2022-12-31 | $-2.11 Million | $-2.89 Million | 1.370x | +8.09% |
| 2021-12-31 | $-3.01 Million | $-3.82 Million | 1.267x | +383.11% |
| 2020-12-31 | $1.61 Million | $423.26K | 0.262x | -- |
About Firefly Neuroscience, Inc.
Firefly Neuroscience, Inc., a medical technology and artificial intelligence company, provides neuroscientific solutions that improve brain health outcomes for patients with mental illnesses and neurological disorders. The company offers Brain Network Analytics, a software that focuses on diagnostic and treatment for people suffering from mental illnesses and cognitive disorders, including depres… Read more